Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H5NO2 |
| Molecular Weight | 111.0987 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=C(O)C=NC=C1
InChI
InChIKey=ZCUUVWCJGRQCMZ-UHFFFAOYSA-N
InChI=1S/C5H5NO2/c7-4-1-2-6-3-5(4)8/h1-3,8H,(H,6,7)
| Molecular Formula | C5H5NO2 |
| Molecular Weight | 111.0987 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Glucosylated deferiprone and its brain uptake: implications for developing glucosylated hydroxypyridinone analogues intended to cross the blood-brain barrier. | 2010-08-12 |
|
| Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties. | 2010-08 |
|
| Preparation of pyridine-3,4-diols, their crystal packing and their use as precursors for palladium-catalyzed cross-coupling reactions. | 2010-04-29 |
|
| Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium. | 2010-04 |
|
| In vitro studies of 3-hydroxy-4-pyridinones and their glycosylated derivatives as potential agents for Alzheimer's disease. | 2010-02-14 |
|
| The selective quantification of iron by hexadentate fluorescent probes. | 2009-12-01 |
|
| Combined chelation based on glycosyl-mono- and bis-hydroxypyridinones for aluminium mobilization: solution and biodistribution studies. | 2009-11 |
|
| Classification of 5-HT(1A) receptor ligands on the basis of their binding affinities by using PSO-Adaboost-SVM. | 2009-07-29 |
|
| Monitoring intracellular labile iron pools: A novel fluorescent iron(III) sensor as a potential non-invasive diagnosis tool. | 2009-06 |
|
| Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives. | 2009-05 |
|
| New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation. | 2009-02 |
|
| Synthesis of 4-pyridone-3-sulfate and an improved synthesis of 3-hydroxy-4-pyridone. | 2009-01-09 |
|
| Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. | 2009-01-08 |
|
| QSAR study of antimicrobial 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives using different chemometric tools. | 2008-12 |
|
| Iron chelation as a potential therapy for neurodegenerative disease. | 2008-12 |
|
| Pyruvate carboxylase is involved in metabolism of mimosine by Rhizobium sp. strain TAL1145. | 2008-10 |
|
| Targeting the lysosome: fluorescent iron(III) chelators to selectively monitor endosomal/lysosomal labile iron pools. | 2008-08-14 |
|
| Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells. | 2008-06-01 |
|
| Gut microbiology - broad genetic diversity, yet specific metabolic niches. | 2008-05 |
|
| A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones. | 2008 |
|
| 55Cobalt complexes with pendant carbohydrates as potential PET imaging agents. | 2007-12 |
|
| Determination of the labile iron pool of human lymphocytes using the fluorescent probe, CP655. | 2007-09-17 |
|
| The pydA-pydB fusion gene produces an active dioxygenase-hydrolase that degrades 3-hydroxy-4-pyridone, an intermediate of mimosine metabolism. | 2007-06 |
|
| Multicomponent assembly of boron-based dendritic nanostructures. | 2007-03-16 |
|
| Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution. | 2006-10-02 |
|
| Selective determination of mimosine and its dihydroxypyridinyl derivative in plant systems. | 2006-10 |
|
| Carbohydrate-appended 3-hydroxy-4-pyridinone complexes of the [M(CO)3]+ core (M = Re, 99mTc, 186Re). | 2006-09-21 |
|
| Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes. | 2006-04-01 |
|
| New lipophilic 3-hydroxy-4-pyridinonate iron(III) complexes: synthesis and EXAFS structural characterisation. | 2006-03-14 |
|
| Synthesis and antiviral evaluation of cyclic and acyclic 2-methyl-3-hydroxy-4-pyridinone nucleoside derivatives. | 2006-01-12 |
|
| Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III). | 2005-11-17 |
|
| High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterization. | 2005-11-15 |
|
| Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga. | 2005-08 |
|
| N-Arylamine derivatives of 3-hydroxy-4-pyridinones: solution studies and bioevaluation in view of Al-detoxification roles. | 2005-01 |
|
| Design, synthesis and properties of novel iron(III)-specific fluorescent probes. | 2004-04 |
|
| Alkylaryl-amino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application. | 2003-09-15 |
|
| The mid genes of Rhizobium sp strain TAL1145 are required for degradation of mimosine into 3-hydroxy-4-pyridone and are inducible by mimosine. | 2003-02 |
|
| Synthesis and physicochemical assessment of novel 2-substituted 3-hydroxypyridin-4-ones, novel iron chelators. | 2002-03 |
|
| Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis. | 2002-03 |
|
| Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase. | 2001-12-28 |
|
| Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes. | 2001-12-15 |
|
| Selection of several classes of mimosine-degradation-defective Tn3Hogus-insertion mutants of Rhizobium sp. strain TAL1145 on the basis of mimosine-inducible GUS activity. | 2001-06 |
|
| Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase. | 2001-02-01 |
|
| Microbial metabolism of the pyridine ring. The metabolism of pyridine-3,4-diol (3,4-dihydroxypyridine) by Agrobacterium sp. | 1974-05 |
|
| Microbial metabolism of the pyridine ring. The hydroxylation of 4-hydroxypyridine to pyridine-3,4-diol (3,4-dihydroxypyridine) by 4-hydroxypyridine-3-hydroxylase. | 1974-05 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:09:17 GMT 2025
by
admin
on
Mon Mar 31 19:09:17 GMT 2025
|
| Record UNII |
UW0C50CU4H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1121-23-9
Created by
admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
|
ALTERNATIVE | |||
|
29053
Created by
admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
|
PRIMARY | |||
|
28630
Created by
admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
|
PRIMARY | |||
|
C007435
Created by
admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
|
PRIMARY | |||
|
DTXSID50274234
Created by
admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
|
PRIMARY | |||
|
10182-48-6
Created by
admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
|
PRIMARY | |||
|
105085
Created by
admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
|
PRIMARY | |||
|
UW0C50CU4H
Created by
admin on Mon Mar 31 19:09:17 GMT 2025 , Edited by admin on Mon Mar 31 19:09:17 GMT 2025
|
PRIMARY |